GlassScriptPhysician profile
Clark Hall
NPI 1225733462
$433.82
in general payments reported to CMS, 2019-2025
13 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $49.37 · 2024: $186 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $104.28 | 2024-2025 | Xerava, Zevtera |
| Melinta Therapeutics, LLC | $71.15 | 2024-2025 | Rezzayo, Orbactiv, Kimyrsa |
| Boston Scientific Corporation | $52.02 | 2023-2025 | Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $46.57 | 2025 | |
| Mylan Specialty L.P. | $23.32 | 2024 | Yupelri |
| Abbott Laboratories | $23.00 | 2025 | Freestyle Libre |
| Viatris Specialty LLC | $19.91 | 2025 | Yupelri |
| Tetraphase Pharmaceuticals, INC. | $17.99 | 2025 | |
| Dexcom, INC. | $15.98 | 2023 | Dexcom G6 Transmitter |
| Aurinia Pharma U.S., INC. | $15.73 | 2024 | Lupkynis |
| Alexion Pharmaceuticals, INC. | $14.98 | 2023 | Ultomiris |
| Exact Sciences Corporation | $14.59 | 2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $14.30 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.